Silvercrest Asset Management Group LLC Maxcyte, Inc. Transaction History
Silvercrest Asset Management Group LLC
- $14.3 Billion
- Q3 2024
A detailed history of Silvercrest Asset Management Group LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 1,091,490 shares of MXCT stock, worth $4.49 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,091,490
Previous 708,163
54.13%
Holding current value
$4.49 Million
Previous $2.78 Million
52.97%
% of portfolio
0.03%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
65.6MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$33.7 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$33.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$23.7 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$20.7 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$19.8 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $418M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...